JEXORI

Swiss trademark · 614609 · Word mark · Deleted

Register entry

Registration number
614609
Application number
51782/2011
Status
Deleted
Type
Word mark
Filed
Feb 15, 2011
Registered
Apr 29, 2011
Published
Apr 29, 2011
Deleted
Sep 8, 2021
Reason
Not renewed
Priority
08.11.2010 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Erzeugnisse für die Behandlung von viralen Erkrankungen, bakteriellen Infekten, zystischer Fibrose, Krebs, Autoimmunkrankheiten, welche chronische Entzündungen oder rheumatoide Arthritis verursachen, Entzündungserkrankungen, neurologische Störungen und Epilepsie.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 8, 2021

    Deleted, not renewed

    Published in Swissreg on 08.09.2021

  2. Feb 1, 2018

    Agent entered

    Representative
    FRORIEP AG, Bellerivestrasse 201, Postfach, 8034 Zürich → Walder Wyss AG, Seefeldstrasse 123, Postfach 1236, 8034 Zürich

    Published in Swissreg on 01.02.2018

  3. Aug 10, 2016

    Agent’s address changed

    Representative
    FRORIEP, Bellerivestrasse 201, 8034 Zürich → FRORIEP AG, Bellerivestrasse 201, Postfach, 8034 Zürich

    Published in Swissreg on 10.08.2016

  4. Apr 4, 2014

    Holder’s address changed

    Owner
    Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, MA 02139-4242, USA → Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston MA 02110, USA

    Published in Swissreg on 04.04.2014

  5. Dec 3, 2013

    Agent’s address changed

    Representative
    Froriep Renggli, Bellerivestrasse 201, 8034 Zürich → FRORIEP, Bellerivestrasse 201, 8034 Zürich

    Published in Swissreg on 03.12.2013

  6. Feb 19, 2013

    Partly deleted

    LGS
    5, Pharmazeutische Erzeugnisse für die Behandlung von viralen Erkrankungen, bakteriellen Infekten, zystischer Fibrose, Krebs, Autoimmunkrankheiten, Entzündungserkrankungen, neurologische Störungen und Epilepsie. → 5, Pharmazeutische Erzeugnisse für die Behandlung von viralen Erkrankungen, bakteriellen Infekten, zystischer Fibrose, Krebs, Autoimmunkrankheiten, welche chronische Entzündungen oder rheumatoide Arthritis verursachen, Entzündungserkrankungen, neurologische Störungen und Epilepsie.
    International classification
    5 → 5

    Published in Swissreg on 19.02.2013

  7. Apr 29, 2011

    Registered

    Published in Swissreg on 29.04.2011

Parties

Holder

Vertex Pharmaceuticals Incorporated

50 Northern Avenue, Boston MA 02110, US

Agent

Walder Wyss AG

Seefeldstrasse 123 Postfach 1236, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.